glp-1 agonists brands List of approved and pending medications GLP-1 Receptor Agonists and Other

However, it acts in contrast with GLP-1 as much as glucagon release is concerned by enhancing its release

It is even more significant in Mounjaro (tirzepatide) which will likely be FDA approved by the end of the year for weight loss

A clinical trial is currently underway exploring the physiological effects of exenatide in reducing ICP in a small cohort of active patients with IIH

On one hand, these medications can help you manage your blood sugar and lose weight, but on the other hand, they can come with some unpleasant side effects

Read Time: 11 min read Key Takeaways Litigation status: Lawsuits involving Ozempic and other GLP-1 drugs have been grouped together in two separate multidistrict litigations (MDL), helping to expedite the legal process